This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 2007-0174OCv1 38/1/78    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Horowitz, J. C. Articles by Thannickal, V. J. Search for Related Content PubMed PubMed Citation Articles by Horowitz, J. C. Articles by Thannickal, V. J.

Plasminogen Activation–Induced Pericellular Fibronectin Proteolysis Promotes Fibroblast Apoptosis

¹ Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan Medical Center, Ann Arbor, Michigan

Correspondence and requests for reprints should be addressed to Jeffrey C. Horowitz, M.D., University of Michigan Medical Center, 6301 MSRB III, 1150 W. Medical Center Dr., Ann Arbor, MI 48109-5642. E mail: jchorow{at}umich.edu

Apoptosis of fibroblasts/myofibroblasts is a critical event in the resolution of tissue repair responses; however, mechanisms for the regulation of (myo)fibroblast apoptosis/survival remain unclear. In this study, we demonstrate counter-regulatory interactions between the plasminogen activation system and transforming growth factor-β1 (TGF-β1) in the control of fibroblast apoptosis. Plasmin treatment induced fibroblast apoptosis in a time- and dose-dependent manner in association with proteolytic degradation of extracellular matrix proteins, as detected by the release of soluble fibronectin peptides. Plasminogen, which was activated to plasmin by fibroblasts, also induced fibronectin proteolysis and fibroblast apoptosis, both of which were blocked by 2-antiplasmin but not by inhibition of matrix metalloproteinase activity. TGF-β1 protected fibroblasts from apoptosis induced by plasminogen but not from apoptosis induced by exogenous plasmin. The protection from plasminogen-induced apoptosis conferred by TGF-β1 is associated with the up-regulation of plasminogen activator-1 (PAI-1) expression and inhibition of plasminogen activation. Moreover, lung fibroblasts from mice genetically deficient in PAI-1 lose the protective effect of TGF-β1 against plasminogen-induced apoptosis. These findings support a novel role for the plasminogen activation system in the regulation of fibroblast apoptosis and a potential role of TGF-β1/PAI-1 in promoting (myo)fibroblast survival in chronic fibrotic disorders.

Key Words: myofibroblast • fibrosis • transforming growth factor-β • anoikis • plasminogen activator inhibitor 1

CLINICAL RELEVANCE Both plasminogen activation and transforming growth factor (TGF)-β1 have been strongly implicated in the pathogenesis of pulmonary fibrosis. This study demonstrates a novel mechanism by which TGF-β1 inhibition of plasminogen activation regulates fibroblast apoptosis.

 

This article has been cited by other articles:

				T.-L. Tuan, P. Hwu, W. Ho, P. Yiu, R. Chang, A. Wysocki, and P. D. Benya Adenoviral Overexpression and Small Interfering RNA Suppression Demonstrate That Plasminogen Activator Inhibitor-1 Produces Elevated Collagen Accumulation in Normal and Keloid Fibroblasts Am. J. Pathol., November 1, 2008; 173(5): 1311 - 1325. [Abstract] [Full Text] [PDF]